Results 71 to 80 of about 71,142 (262)

Behavioral Impulsivity in Obsessive–Compulsive Disorder

Journal of Behavioral Addictions, 2016
Background Grassi et al. (2015) collected data to examine impulsivity in individuals with obsessive–compulsive disorder (OCD) compared to nonpsychiatric controls. Their aim was to examine whether OCD may be fully captured by the behavioral addiction model, using the prototypical mechanism underlying drug addiction as their ...
Abramovitch, Amitai, McKay, Dean
openaire   +3 more sources

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source

Drivers of Sustainability Disclosure in the Healthcare Sector: Empirical Evidence From Portugal

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study examines the determinants of online sustainability disclosure in the Portuguese public hospital sector, contributing to the growing literature on sustainability disclosure in healthcare organizations from a context that remains largely underexplored.
Yolanda Ramírez, Francisco Montero
wiley   +1 more source

A Case of Ropinirole-Induced Compulsive Behavior

The Primary Care Companion For CNS Disorders, 2012
To the Editor: Parkinson’s disease is a neuropsychiatric condition. Dopamine agonists are used extensively in the treatment of Parkinson’s. A retrospective review in 2009 of patients with Parkinson’s disease reported a frequency of 13.2% for compulsive behavior including new-onset pathological gambling and hypersexuality after being started on ...
Harmit, Singh, Mary Theresa, Veglia, Sriram, Ramaswamy   +2 more
openaire   +3 more sources

Winning Consumer Trust Through Supply Chain Responsibility Communication: How Certification, Disclosure, and Beneficiary Framing Shape Credibility

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT As stakeholders increasingly demand supply chain transparency, companies face a legitimacy paradox: disclosing supply chain responsibility (SR) information is necessary to meet stakeholder expectations, yet disclosure can invite scrutiny rather than build credibility.
Julia Hartmann
wiley   +1 more source

The Cognitive Drivers of Compulsive Eating Behavior

Frontiers in Behavioral Neuroscience, 2019
Compulsivity is a central feature of obsessive-compulsive and addictive disorders, which share considerable overlap with excessive eating in terms of repetitive behavior despite negative consequences. Excessive eating behavior is characteristic of several eating-related conditions, including eating disorders [bulimia nervosa (BN), binge eating disorder
Naomi Kakoschke, Esther Aarts, Antonio Verdejo-García   +2 more
openaire   +3 more sources

Longitudinal Residential Eating Disorder Treatment Outcomes for Binge‐Eating Disorder When Using the Unified Treatment Model

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Despite its prevalence, research on binge‐eating disorder (BED) outcomes for residential treatment remains limited. To address this research scarcity, we evaluated changes in ED behaviors and comorbid symptoms, including depression and anxiety, for patients with BED that received residential eating disorder (ED) care from a ...
Kiki M. Kline, Briana Delibashi, Gayle Brooks, Shelby N. Ortiz   +3 more
wiley   +1 more source

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Eating disorders (EDs) are characterized by high rates of psychiatric comorbidity and suboptimal treatment outcomes. There remain critical gaps in research, including the exploration of effective transdiagnostic interventions. This forum article examines the potential of psilocybin treatment (PT) as a transdiagnostic intervention for
Elena Koning, Jérémie Richard, Aaron Keshen   +2 more
wiley   +1 more source

GLP‐1 Receptor Agonism Exacerbates Activity‐Based Anorexia in Mice

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Glucagon‐like peptide‐1 receptor (GLP‐1R) agonists reduce food intake and body weight, suggesting they should be avoided in anorexia nervosa. However, preclinical evidence that these drugs reduce activity and reward‐seeking behavior raises the possibility that they might attenuate the compulsive‐like hyperactivity central to ABA ...
Amit Thakar, Travis E. Brown, Shane T. Hentges   +2 more
wiley   +1 more source

Algorithm‐Defined Muscle Dysmorphia Estimates Across Weighting and Case‐Definition Strategies in a Gender‐Balanced Adult Online Sample

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Epidemiological evidence on muscle dysmorphia (MD) remains limited, and self‐report algorithm‐defined estimates may depend on sampling and case definitions. We examined how algorithm‐defined MD estimates and exploratory correlates varied across weighting and case‐definition scenarios in a gender‐balanced German online sample.
Christopher Zaiser, Nora M. Laskowski, Georg Halbeisen, Marietta Lieb, Georgios Paslakis   +4 more
wiley   +1 more source